Search
Showing results for "1"
Research
The CoolCot trial: active methods of therapeutic hypothermia for newborns with hypoxic ischaemic encephalopathy during neonatal transport: a study protocol for a randomised controlled trialImpaired oxygen delivery or blood flow to the brain around the time of birth can cause injury. Hypoxic ischaemic encephalopathy is a leading cause of death and disability in term and near-term infants.
Research
Study protocol for Healthy Conversations @ Playgroup: a multi-site cluster randomized controlled trial of an intervention to promote healthy lifestyle behaviours in young children attending community playgroupsEarly childhood is a critical window for preventing obesity and chronic disease. Yet, 1 in 4 Australian children aged 5 years and under are affected by overweight or obesity; and significant proportions of children under 5 years fail to meet guidelines for diet quality, physical activity (PA), screen time, and sleep.
Research
Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1)Amoxicillin-clavulanate treatment is beneficial in terms of resolution of non-severe exacerbations of bronchiectasis in children
Consumer Representative Lauren Hope-Blyth
News & Events
Help our kids reach their potentialYou're invited to join the Early Childhood Development and Learning Collaboration on Monday 15 August from 7pm to help every child reach their potential.
Research
Development of a Model of Care resource for FASD in the justice systemThis article describes the development of a Model of Care resource to support youth involved with the justice system where a neurodevelopmental disability such as Fetal Alcohol Spectrum Disorder is suspected. Service staff within the Youth Justice sector were engaged in an iterative process of resource development over a 9-month period.
News & Events
Oral insulin studyDiabetes researchers from Perth Children’s Hospital would like to find out whether oral insulin is useful in T1D management and is safe for use in individuals with T1D. They are looking for participants aged 16 – 25 years to be involved in their Oral Insulin 12-week study.
News & Events
Guardian 4 sensorThe Guardian 4 sensor have recently been approved by the Therapeutic Goods Administration for use in Australia.
News & Events
Kids have a 'wild' time at diabetes campKids living with type 1 diabetes got to hang out with peers and have a lot of fun at the Diabetes WA and Perth Children’s Hospital kids’ camp in Bicton recently.